TAMARA LEE: Open Payments
NPI 1992720965 · ROSEBURG, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$193 in 11 payments from 5 companies in 2025. Trend: 2023 $324 · 2024 $330 · 2025 $193
Food & beverage: $193
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 3 | $51 |
| E.R. Squibb & Sons, L.L.C. | 2 | $38 |
| Vanda Pharmaceuticals Inc. | 2 | $36 |
| Otsuka America Pharmaceutical, Inc. | 2 | $34 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $34 |
Products named: Auvelity, COBENFY, FANAPT, REXULTI, CAPLYTA.
Industry payments across OR — which companies pay providers there.
